# Nyaditum Resae® as a Co-adjuvant During Treatment for Active Pulmonary Tuberculosis and Its Impact on the Gut Microbiota

> **NCT03851159** · NA · ACTIVE_NOT_RECRUITING · sponsor: **University of Stellenbosch** · enrollment: 48 (actual)

## Conditions studied

- Tuberculosis

## Interventions

- **DIETARY_SUPPLEMENT:** Nyaditum resae®
- **OTHER:** Mannitol

## Key facts

- **NCT ID:** NCT03851159
- **Lead sponsor:** University of Stellenbosch
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2019-05-10
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2026-05-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03851159

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03851159, "Nyaditum Resae® as a Co-adjuvant During Treatment for Active Pulmonary Tuberculosis and Its Impact on the Gut Microbiota". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03851159. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*